| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
35 |
| Employees |
2,046 |
| Revenues (TTM) (Millions $) |
507 |
| Net Income (TTM) (Millions $) |
-87 |
| Cash Flow (TTM) (Millions $) |
-4 |
| Capital Exp. (TTM) (Millions $) |
14 |
Business Description
Inotiv Inc. is a leading provider of contract research services to the pharmaceutical, biotechnology, and medical device industries. The company was founded in 1992 and is headquartered in West Lafayette, Indiana, USA. Inotiv has a long history of providing high-quality analytical and bioanalytical services, as well as other technical services such as pharmacokinetic and toxicology studies.
Inotiv's services include bioanalysis, preclinical and clinical pharmacology, and clinical trial management. Their bioanalysis services help clients determine the concentration of drug molecules in blood, plasma, or other fluids. The preclinical and clinical pharmacology services include dose ranging studies, pharmacokinetics and pharmacodynamics studies, as well as toxicology studies, where they use animal models to evaluate the safety of drugs. Inotiv's clinical trial management services involve the coordination and management of clinical trials, including the selection of investigators, the design and implementation of protocols, and the management of data.
Inotiv is an accredited laboratory with over 20 years of experience in the industry, and their team of scientists and technicians possess the expertise and the knowledge to provide clients with the highest quality services. They have state-of-the-art facilities and equipment, which allows them to offer a broad range of analytical and bioanalytical services that meet or exceed regulatory requirements.
Inotiv's clients include pharmaceutical and biotechnology companies, as well as academic and government institutions. They have a significant presence in North America, Europe, and Asia, and their services have been relied upon to support the development of hundreds of drugs and medical devices.
In terms of financial performance, Inotiv has consistently grown revenues year over year, and has been profitable for over a decade. As of 2021, the company has a market capitalization of more than $350 million, making it a relatively small player in the contract research industry.
Overall, Inotiv's commitment to excellence in science, rigorous quality assurance, and a focus on customer satisfaction has made it a highly trusted partner to many of the world's leading pharmaceutical and biotechnology companies.
Company Address: 2701 KENT AVENUE WEST LAFAYETTE 47906 IN
Company Phone Number: 463-4527 Stock Exchange / Ticker: NASDAQ NOTV
|
%
0.37% 
-2.9 %